Restoration of microRNA‑29c in type I endometrioid cancer reduced endometrial cancer cell growth

  • Authors:
    • Michelle Van Sinderen
    • Meaghan Griffiths
    • Ellen Menkhorst
    • Keith Niven
    • Evdokia Dimitriadis
  • View Affiliations

  • Published online on: July 9, 2019     https://doi.org/10.3892/ol.2019.10588
  • Pages: 2684-2693
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endometrial cancer is the most common gynaecological cancer worldwide, and the prognosis of patients with advanced disease remains poor. MicroRNAs (miRs) are dysregulated in endometrial cancer. miRs‑29‑a, ‑b and ‑c expression levels are downregulated in endometrial cancer; however, a specific role for miR‑29c and its target genes remain to be elucidated. The aim of the present study was to determine the functional effect of restoring miR‑29c expression in endometrial cancer cell lines and to identify miR‑29c targets involved in cancer progression. miR‑29c expression in human endometrial tumour grades 1‑3 and benign tissue as well as in the endometrial cancer cell lines Ishikawa, HEC1A and AN3CA were analysed using reverse transcriptase‑quantitative PCR (RT‑qPCR). The cell lines were transfected with miR‑29c mimic, miR‑29c inhibitor or scrambled control. xCELLigence real‑time cell monitoring analysed proliferation and migration, and flow cytometry was used to analyse apoptosis and cell cycle. The expression of miR‑29c target genes in transfected cell lines was analysed using RT‑qPCR. miR‑29c was downregulated in grade 1‑3 endometrial cancer samples compared with benign endometrium. miR‑29c was reduced in Ishikawa and AN3CA cells, but not in HEC1A cell lines compared with non‑cancerous primary human endometrial epithelial cells. Overexpression of miR‑29c variably reduced proliferation, increased apoptosis and reduced the expression levels of miR‑29c target genes, including cell division cycle 42, HMG‑box transcription factor 1, integrin subunit β 1, MCL1 apoptosis regulator BCL2 family member, MDM2 proto‑oncogene, serum/glucocorticoid regulated kinase 1, sirtuin 1 and vascular endothelial growth factor A, across the three cell lines investigated. Inhibition of miR‑29c in HEC1A cells increased proliferation and collagen type IV α 1 chain expression. The re‑introduction of miR‑29c to endometrial cancer cell lines reduced proliferation, increased apoptosis and reduced miR‑29c target gene expression in vitro. The present results suggested that miR‑29c may be a potential therapeutic target for endometrial cancer.

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Van Sinderen, M., Griffiths, M., Menkhorst, E., Niven, K., & Dimitriadis, E. (2019). Restoration of microRNA‑29c in type I endometrioid cancer reduced endometrial cancer cell growth. Oncology Letters, 18, 2684-2693. https://doi.org/10.3892/ol.2019.10588
MLA
Van Sinderen, M., Griffiths, M., Menkhorst, E., Niven, K., Dimitriadis, E."Restoration of microRNA‑29c in type I endometrioid cancer reduced endometrial cancer cell growth". Oncology Letters 18.3 (2019): 2684-2693.
Chicago
Van Sinderen, M., Griffiths, M., Menkhorst, E., Niven, K., Dimitriadis, E."Restoration of microRNA‑29c in type I endometrioid cancer reduced endometrial cancer cell growth". Oncology Letters 18, no. 3 (2019): 2684-2693. https://doi.org/10.3892/ol.2019.10588